1
|
Du HM, Li JJ, Dou F, Zhao YN, Ma ZB, Yang C, Hu XB. [Impact of social support for schizophrenia patients on their quality of life and family life satisfaction]. Zhonghua Liu Xing Bing Xue Za Zhi 2023; 44:786-790. [PMID: 37221068 DOI: 10.3760/cma.j.cn112338-20220929-00830] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Subscribe] [Scholar Register] [Indexed: 05/25/2023]
Abstract
Objective: To explore the relationship of social support to patients with schizophrenia, family burden with patients' quality of life and family life satisfaction. Methods: Multi-stage stratified cluster random sampling was used to select 358 patients with schizophrenia and 358 patients' family members in Gansu Province who met the inclusion criteria were included. The Social Support Rating Scale, Family Burden Scale, Satisfaction with Life Scale and Quality of Life Scale were used in the survey. AMOS 24.0 was used to explore the pathway of influence of family burden on social support to patients with schizophrenia, patients' quality of life and patients' family life satisfaction. Results: There was a two-by-two significant correlation between patients' access to social support, family burden, patients' life quality and family life satisfaction (P<0.05), and the total score of the social support scale negatively predicted the total score of the life quality scale (β=-0.28, P<0.05) and positively predicted the total score of the life satisfaction scale (β=0.52, P<0.05). Family burden was a full mediator between the social support to the patient and the patient's quality of life, and as a partial mediator between the social support to the patient and the family's life satisfaction. Conclusions: Social support to people with schizophrenia is a significant predictor of their quality of life and family life satisfaction. Family burden mediates the relationship of social support to patients with their quality of life and family life satisfaction. Interventions can focus on increasing social support for the patient and reducing the burden on the patient's family to improve the patient's quality of life and increase the satisfaction of the patient's family.
Collapse
Affiliation(s)
- H M Du
- Department of Epidemiology and Health Statistics, School of Public Health, Lanzhou University, Lanzhou 730000, China
| | - J J Li
- Department of Epidemiology and Health Statistics, School of Public Health, Lanzhou University, Lanzhou 730000, China
| | - F Dou
- Department of Epidemiology and Health Statistics, School of Public Health, Lanzhou University, Lanzhou 730000, China
| | - Y N Zhao
- Department of Epidemiology and Health Statistics, School of Public Health, Lanzhou University, Lanzhou 730000, China
| | - Z B Ma
- Department of Epidemiology and Health Statistics, School of Public Health, Lanzhou University, Lanzhou 730000, China
| | - C Yang
- Department of Epidemiology and Health Statistics, School of Public Health, Lanzhou University, Lanzhou 730000, China
| | - X B Hu
- Department of Epidemiology and Health Statistics, School of Public Health, Lanzhou University, Lanzhou 730000, China
| |
Collapse
|
2
|
Dou F, Lu Y, Nitin N. Yeast cell microcarriers for delivery of a model bioactive compound in skin. Int J Pharm 2021; 609:121123. [PMID: 34560206 DOI: 10.1016/j.ijpharm.2021.121123] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2020] [Revised: 09/11/2021] [Accepted: 09/19/2021] [Indexed: 01/22/2023]
Abstract
This study aimed at developing a cell-based encapsulation carrier for topical delivery of bioactives to the skin. The overall objectives were to evaluate affinity of the yeast-cell based carrier to bind to the skin surface following topical application and to quantify controlled release of curcumin as a model bioactive in ex-vivo skin models using a combination of imaging, modeling and analytical measurements. Both porcine skin tissue and clinically obtained human skin biopsies were studied. The results demonstrated that upon incubation with the ex-vivo skin tissues, the cell carriers rapidly bound to the skin surface following topical delivery and provided sustained release of encapsulated curcumin. The microcarrier binding and penetration of curcumin in the dermal compartment also showed to increase with incubation time. The average flux of curcumin in human skin biopsies Jp was 0.89 ± 0.02 μg/cm2/h. These results illustrated the potential of a novel cell-based carrier for high affinity binding to skin surface, efficient encapsulation of a model bioactive and controlled release from the cell carrier to the skin with enhanced permeation to the dermis section. Overall, this study demonstrated a new class of cost-effective carriers for improving delivery of bioactives to the skin and potentially other epithelial tissues.
Collapse
Affiliation(s)
- Fang Dou
- Department of Food Science and Technology, University of California, Davis, CA 95616, USA
| | - Yixing Lu
- Department of Food Science and Technology, University of California, Davis, CA 95616, USA
| | - Nitin Nitin
- Department of Food Science and Technology, University of California, Davis, CA 95616, USA; Department of Biological and Agricultural Engineering, University of California, Davis, CA 95616, USA.
| |
Collapse
|
3
|
Dou F, Huang K, Nitin N. Targeted Photodynamic Treatment of Bacterial Biofilms Using Curcumin Encapsulated in Cells and Cell Wall Particles. ACS Appl Bio Mater 2021; 4:514-522. [PMID: 35014299 DOI: 10.1021/acsabm.0c01051] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
Abstract
Efficient inactivation and removal of pathogenic biofilms in food and biomedical environments remain a significant challenge for food safety applications and medical facilities. This research aims to develop food-grade microcarriers for the targeted delivery of a photosensitizer, curcumin, and photodynamic inactivation of a model pathogenic bacterial biofilm. The microcarriers evaluated in this study include alive yeast cell carriers, deactivated yeast cell carriers, and yeast cell wall particles. The microcarriers were evaluated based on the encapsulation yield of a model photosensitizer (curcumin), binding of the microcarriers to biofilms, and inactivation of the bacteria in the biofilms. The results illustrate that the combination of binding affinity, encapsulation yield, and the intracellular composition of the microcarriers influenced the overall inactivation of bacteria in the biofilms. All of the selected compositions achieved more than 93% inactivation of the bacteria in the biofilm using the photodynamic treatment, and the yeast cell wall particles with curcumin achieved over 99% inactivation of the bacteria in the biofilm matrix. In addition, all of the selected compositions demonstrated significant potential to remove the biofilm from the plastic surface, suggesting the role of binding affinity of the microcarriers in removal of the biofilm from surfaces. Overall, this study developed biomaterial formulations for targeted photodynamic inactivation and potential removal of biofilms.
Collapse
Affiliation(s)
- Fang Dou
- Department of Food Science and Technology, University of California, Davis, California 95616, United States
| | - Kang Huang
- School of Chemical Sciences, The University of Auckland, Auckland 1010, New Zealand
| | - Nitin Nitin
- Department of Food Science and Technology, University of California, Davis, California 95616, United States.,Department of Biological and Agricultural Engineering, University of California, Davis, California 95616, United States
| |
Collapse
|
4
|
Dou F, Ding Y, Wang C, Duan J, Wang W, Xu H, Zhao X, Wang J, Wen A. Chrysophanol ameliorates renal interstitial fibrosis by inhibiting the TGF-β/Smad signaling pathway. Biochem Pharmacol 2020; 180:114079. [PMID: 32511988 DOI: 10.1016/j.bcp.2020.114079] [Citation(s) in RCA: 30] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2020] [Revised: 06/01/2020] [Accepted: 06/03/2020] [Indexed: 02/06/2023]
Abstract
Renal interstitial fibrosis (RIF) is a major pathological feature of chronic kidney disease at middle and end stages. Chrysophanol (CP), 1,8-dihydroxy-3-methyl-9,10-anthraquinone, is an anthraquinone isolated from Rheum palmatum L. with a variety of pharmacological activities including the suppression of RIF. However, the effect of CP on renal fibrosis and its potential mechanism have not been elucidated. We conducted a comprehensive study by determining the expression levels of fibrotic markers and proteins including TGF-β1, α-SMA, and Smad3 related to transforming growth factor-beta/Smad (TGF-β/Smad) pathway in unilateral ureteral obstruction (UUO) mice and TGF-β1-stimulated HK-2 cells with the treatment of CP using western blotting and RT-qPCR analyses. Using small interfering RNA and co-immunoprecipitation, we evaluated the influences of CP on the interactions between Smad3 and Smad7 proteins and also on TGF-β RI and TGF-βR II. We found that CP administration significantly ameliorated UUO-induced kidney damage by reversing abnormal serum and urine biochemical parameters and decreasing the production of fibrotic markers including collagen I, collagen III, fibronectin, and α-SMA. Our results showed that TGF-β1 and phospho-Smad3 (p-Smad3) expression was significantly down-regulated and Smad7 expression was up-regulated by CP in UUO mice compared to the model group; however, the expression of Smad2, Smad4, and TGF-β receptors was not affected. Furthermore, CP modulated these fibrotic markers as well as p-Smad3 and Smad7 in TGF-β1-induced HK-2 cells. The inhibitory effect of CP was markedly reduced in TGF-β1-treated HK-2 cells transfected with Smad3 siRNA. Additionally, co-immunoprecipitation analysis indicated that CP blocked the interaction between Smad3 and TGF-β receptor I to suppress p-Smad3 expression. These findings demonstrated that CP alleviated RIF by inhibiting Smad3 phosphorylation, which provides a molecular basis for a new drug candidate for the treatment of RIF.
Collapse
Affiliation(s)
- Fang Dou
- Department of Pharmacy, Xijing Hospital, Fourth Military Medical University, No. 127, West Changle Road, Xi'an, Shaanxi 710032, China.
| | - Yi Ding
- Department of Pharmacy, Xijing Hospital, Fourth Military Medical University, No. 127, West Changle Road, Xi'an, Shaanxi 710032, China
| | - Cheng Wang
- School of Pharmacy, Xi'an Jiaotong University, Xi'an, Shaanxi 710061, China
| | - Jialin Duan
- Department of Pharmacy, Xijing Hospital, Fourth Military Medical University, No. 127, West Changle Road, Xi'an, Shaanxi 710032, China
| | - Wenjun Wang
- Department of Pharmacy, Xijing Hospital, Fourth Military Medical University, No. 127, West Changle Road, Xi'an, Shaanxi 710032, China
| | - Hang Xu
- Department of Pharmacy, Xijing Hospital, Fourth Military Medical University, No. 127, West Changle Road, Xi'an, Shaanxi 710032, China
| | - Xian Zhao
- Department of Pharmacy, Xijing Hospital, Fourth Military Medical University, No. 127, West Changle Road, Xi'an, Shaanxi 710032, China
| | - Jingwen Wang
- Department of Pharmacy, Xijing Hospital, Fourth Military Medical University, No. 127, West Changle Road, Xi'an, Shaanxi 710032, China.
| | - Aidong Wen
- Department of Pharmacy, Xijing Hospital, Fourth Military Medical University, No. 127, West Changle Road, Xi'an, Shaanxi 710032, China.
| |
Collapse
|
5
|
Wang W, Liu T, Yang L, Ma Y, Dou F, Shi L, Wen A, Ding Y. Study on the multi-targets mechanism of triphala on cardio-cerebral vascular diseases based on network pharmacology. Biomed Pharmacother 2019; 116:108994. [PMID: 31112872 DOI: 10.1016/j.biopha.2019.108994] [Citation(s) in RCA: 37] [Impact Index Per Article: 7.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/27/2019] [Revised: 05/01/2019] [Accepted: 05/13/2019] [Indexed: 12/14/2022] Open
Abstract
BACKGROUND & AIMS Numerous references made clear that Triphala is revered as a multiuse therapeutic and perhaps even panacea historically. Nevertheless, the protective mechanism of Triphala on cardio-cerebral vascular diseases (CCVDs) remains not comprehensive understanding. Hence, a network pharmacology-based method was suggested in this study to address this problem. METHODS This study was based on network pharmacology and bioinformatics analysis. Information on compounds in herbal medicines of Triphala formula was acquired from public databases. Oral bioavailability as well as drug-likeness were screened by using absorption, distribution, metabolism, and excretion (ADME) criteria. Then, components of Triphala, candidate targets of each component and known therapeutic targets of CCVDs were collected. Compound-target gene and compounds-CCVDs target networks were created through network pharmacology data sources. In addition, key targets and pathway enrichment were analyzed by STRING database and DAVID database. Moreover, we verified three of the key targets (PTGS2, MMP9 and IL6) predicted by using western blot analysis. RESULTS Network analysis determined 132 compounds in three herbal medicines that were subjected to ADME screening, and 23 compounds as well as 65 genes formed the principal pathways linked to CCVDs. And 10 compounds, which actually linked to more than three genes, are determined as crucial chemicals. Core genes in this network were IL6, TNF, VEGFA, PTGS2, CXCL8, TP53, CCL2, IL10, MMP9 and SERPINE1. And pathways in cancer, TNF signaling pathway, neuroactive ligand-receptor interaction, etc. related to CCVDs were identified. In vitro experiments, the results indicated that compared with the control group (no treatment), PTGS2, MMP9 and IL6 were up-regulated by treatment of 10 ng/mL TNF-α, while pretreatment with 20-80 μg/mL Triphala could significantly inhibit the expression of PTGS2, MMP9 and IL6. With increasing Triphala concentration, the expression of PTGS2, MMP9 and IL6 decreased. CONCLUSIONS This study revealed the complex components and pharmacological mechanism of Triphala, and obtained some potential therapeutic targets of CCVDs, which could provide theoretical basis for the research and development of new drugs for treating CCVDs.
Collapse
Affiliation(s)
- Wenjun Wang
- Department of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, China; College of Pharmacy, Shaanxi University of Chinese Medicine, Xi'an, 712000, China
| | - Tianlong Liu
- Department of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, China; Department of Pharmacy, 940 Hospital of PLA Joint Logistics Support Forces, Lanzhou, 730050, China
| | - Liudi Yang
- Department of Acupuncture-moxibustion-massage, Shaanxi University of Chinese Medicine, Xi'an, 712000, China
| | - Yang Ma
- College of Pharmacy, Shaanxi University of Chinese Medicine, Xi'an, 712000, China
| | - Fang Dou
- Department of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, China
| | - Lei Shi
- Department of Pharmacy, Guangzhou General Hospital of Guangzhou Military Command, Guangzhou, 510000, China
| | - Aidong Wen
- Department of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, China.
| | - Yi Ding
- Department of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, China; Department of Pharmacy, Guangzhou General Hospital of Guangzhou Military Command, Guangzhou, 510000, China.
| |
Collapse
|
6
|
Huang K, Dou F, Nitin N. Biobased Sanitizer Delivery System for Improved Sanitation of Bacterial and Fungal Biofilms. ACS Appl Mater Interfaces 2019; 11:17204-17214. [PMID: 30997985 DOI: 10.1021/acsami.9b02428] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
Biofilms can persist in food-processing environments because of their relatively higher tolerance and resistance to antimicrobials including sanitizers. In this study, a novel biobased sanitizer composition was developed to effectively target biofilms and deliver chlorine-based sanitizers to inactivate bacterial and fungal biofilms. The biobased composition was developed by encapsulating a chlorine-binding polymer in a biobased yeast cell wall particle (YCWP) microcarrier. This study demonstrates the high affinity of biobased compositions to bind target bacterial and fungal cells and inactivate 5 logs of model pathogenic bacteria and fungi in wash water without and with high organic load (chemical oxygen demand = 2000 mg/L) in 30 s and 5 min, respectively. For the sanitation of biofilms, this biobased sanitizer can inactivate 7 logs of pathogenic bacteria and 3 logs of fungi after 1 h treatment, whereas the 1 h treatment using conventional chlorine-based sanitizer can only achieve 2-3 log reduction for bacterial biofilms and 1-2 log reduction for fungal biofilms, respectively. The enhanced antimicrobial activity can be attributed to three factors: (a) localized high concentration of chlorine bound on the YCWPs; (b) high affinity of YCWPs to bind diverse microbes; and (c) improved stability in an organic-rich aqueous environment. In summary, these unique attributes of biobased carriers will significantly enhance the sanitation efficacy of biofilms, reduce the persistence and transmission of antimicrobial resistant microbes, limit the use of antimicrobial chemicals, and improve the cost-effectiveness of sanitizers.
Collapse
|
7
|
Xu H, Liu T, Wang W, Su N, Yang L, Yang Z, Dou F, Cui J, Fei F, Ma J, Wen A, Ding Y. Proteomic Analysis of Hydroxysafflor Yellow A Against Cerebral Ischemia/Reperfusion Injury in Rats. Rejuvenation Res 2019; 22:503-512. [PMID: 30712471 DOI: 10.1089/rej.2018.2145] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022] Open
Abstract
Hydroxysafflor yellow A (HSYA), an active component from Chinese medicinal herb, has been applied to the prevention and treatment of cerebral ischemia/reperfusion injury (CIRI). To clarify the comprehensive mechanisms HSYA for stroke, we used label-free quantitative proteomic analysis to investigate the modulated proteins of rats subjected to CIRI and their alteration by HSYA. Neurological examination, infarct assessment, and biochemical assay were performed to validate the effects of HSYA, and the results indicated that HSYA played a significant role in brain protection. A total of 13 proteins were identified as overlapped proteins by label-free quantitative proteomic analysis. Gene Ontology and pathway analysis showed that these differentially expressed proteins were mainly enriched in the hypoxia-inducible factor 1 (HIF-1) signaling pathway. Furthermore, networks were constructed with respect to protein function interactions. The results suggested that seven proteins were identified as hub proteins between model and sham groups, while 25 proteins were identified as hub proteins between HSYA and model groups. In addition, the expressions of three overlapping proteins were validated by Western blot, and their levels were consistent with the results of label-free analysis. In conclusion, Eftud2, mTOR, Rab11, Ppp2r5e, and HIF-1 signaling pathways have been detected as key hub proteins and pathways in HSYA against CIRI through proteomic analysis. Our research has provided convincing explanations for the mechanism of HSYA against CIRI and the identified key proteins and pathways might provide novel therapeutics for CIRI.
Collapse
Affiliation(s)
- Hang Xu
- Department of Pharmacy, Xijing Hospital, the Fourth Military Medical University, Xi'an, China
| | - Tianlong Liu
- Department of Pharmacy, Xijing Hospital, the Fourth Military Medical University, Xi'an, China
| | - Wenjun Wang
- College of Pharmacy, Shaanxi University of Chinese Medicine, Xi'an, China
| | - Ning Su
- Department of Radiation Oncology, Xijing Hospital, the Fourth Military Medical University, Xi'an, China
| | - Liudi Yang
- Department of Acupuncture-moxibustion-massage, Shaanxi University of Chinese Medicine, Xi'an, China
| | - Zhifu Yang
- Department of Pharmacy, Xijing Hospital, the Fourth Military Medical University, Xi'an, China
| | - Fang Dou
- Department of Pharmacy, Xijing Hospital, the Fourth Military Medical University, Xi'an, China
| | - Jia Cui
- Department of Pharmacy, Xijing Hospital, the Fourth Military Medical University, Xi'an, China
| | - Fei Fei
- Department of Ophthalmology, Xijing Hospital, the Fourth Military Medical University, Xi'an, China
| | - Jing Ma
- Department of Traditional Chinese Medicine, Xijing Hospital, the Fourth Military Medical University, Xi'an, China
| | - Aidong Wen
- Department of Pharmacy, Xijing Hospital, the Fourth Military Medical University, Xi'an, China
| | - Yi Ding
- Department of Pharmacy, Xijing Hospital, the Fourth Military Medical University, Xi'an, China
| |
Collapse
|
8
|
Dou F, Liu Y, Liu L, Wang J, Sun T, Mu F, Guo Q, Guo C, Jia N, Liu W, Ding Y, Wen A. Aloe-Emodin Ameliorates Renal Fibrosis Via Inhibiting PI3K/Akt/mTOR Signaling Pathway In Vivo and In Vitro. Rejuvenation Res 2018; 22:218-229. [PMID: 30215298 DOI: 10.1089/rej.2018.2104] [Citation(s) in RCA: 64] [Impact Index Per Article: 10.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023] Open
Abstract
Fibrosis is the major pathological feature of chronic kidney disease (CKD). Aloe-emodin (AE), one of the main active compounds in Rhubarb, is widely used for renal protection. However, mechanisms implied in the modulation of kidney fibrosis after AE treatment for CKD remain elusive. Here, we explored the protective effects of AE for renal fibrosis and the involved mechanisms in vivo and in vitro. The renal fibrosis mice model was established by unilateral ureteral obstruction (UUO). We found that AE administration significantly ameliorated UUO-induced impairment of kidney, evidenced by improved histopathological abnormalities, body weight, and abnormal renal function in mice model. Immunohistochemical staining showed that TGF-β1 and Fibronectin expressions were significantly decreased in UUO mice compared with sham group. Meanwhile, we found that AE suppressed the activation of the PI3K/Akt/mTOR pathway induced by TGF-β1 in vivo. AE improved cell survival and decreased the level of fibrosis-related proteins under TGF-β1-induced fibrosis in HK-2 cells as well as in vitro. Furthermore, both wortmannin, an inhibitor of PI3K, and short-hairpin RNAs of PI3K knockdown abrogated TGF-β1-induced phosphorylation of Akt and mTOR, and decreased the suppression of fibrosis. These findings indicated that AE alleviated fibrosis by inhibiting PI3K/Akt/mTOR pathway in vivo and in vitro, which may provide a potential therapeutic option for CKD.
Collapse
Affiliation(s)
- Fang Dou
- 1 Department of Pharmacy, Xijing Hospital, The Fourth Military Medical University, Xian, China
| | - YueTong Liu
- 2 Department of Endocrinology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China
| | - Limin Liu
- 3 Department of Nephrology, Xijing Hospital, Fourth Military Medical University, Xian, China
| | - Jingwen Wang
- 1 Department of Pharmacy, Xijing Hospital, The Fourth Military Medical University, Xian, China
| | - Ting Sun
- 4 Precision Pharmacy & Drug Development Center, Department of Pharmacy, Tangdu Hospital, Fourth Military Medical University, Xian, China
| | - Fei Mu
- 1 Department of Pharmacy, Xijing Hospital, The Fourth Military Medical University, Xian, China
| | - Qiyan Guo
- 5 Department of Radiation Medicine, Faculty of Preventive Medicine, Fourth Military Medical University, Xian, China
| | - Chao Guo
- 1 Department of Pharmacy, Xijing Hospital, The Fourth Military Medical University, Xian, China
| | - Na Jia
- 1 Department of Pharmacy, Xijing Hospital, The Fourth Military Medical University, Xian, China
| | - Wenxin Liu
- 1 Department of Pharmacy, Xijing Hospital, The Fourth Military Medical University, Xian, China
| | - Yi Ding
- 1 Department of Pharmacy, Xijing Hospital, The Fourth Military Medical University, Xian, China
| | - Aidong Wen
- 1 Department of Pharmacy, Xijing Hospital, The Fourth Military Medical University, Xian, China
| |
Collapse
|
9
|
Liu W, Mu F, Liu T, Xu H, Chen J, Jia N, Zhang Y, Dou F, Shi L, Li Y, Wen A, Ding Y. Ultra Performance Liquid Chromatography/Quadrupole Time-of-Flight Mass Spectrometry-Based Metabonomics Reveal Protective Effect of Terminalia chebula Extract on Ischemic Stroke Rats. Rejuvenation Res 2018; 21:541-552. [PMID: 29804491 DOI: 10.1089/rej.2018.2082] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
Terminalia chebula (TC), a kind of Combretaceae, is a widely used herb in India and East Asia to treat cerebrovascular diseases. However, the potential mechanism of the neuroprotective effects of TC at the metabonomics level is still not clear. The present study focused on the effects of TC on metabonomics in a stroke model. Rats were divided randomly into sham, model, and TC groups. Rats in the TC group were intragastrically administered with TC for 7 days after a middle cerebral artery occlusion (MCAO) operation. The sham and the model groups received vehicle for the same length of time. Subsequently, the neuroprotective effects of TC were examined by evaluation of neurological defects, assessment of infarct volume, and identification of biochemical indicators for antioxidant and anti-inflammatory activities. Further, metabonomics technology was employed to evaluate the endogenous metabolites profiling systematically. Consist with the results of biochemical and histopathological assays, pattern recognition analysis showed a clear separation of the model group and the sham group, indicating the recovery impact of TC on the MCAO rats. Moreover, 12 potential biomarkers were identified in the MCAO model group, involving energy (lactic acid, succinic acid, and fumarate), amino acids (leucine, alanine, and phenylalanine), and glycerophospholipid (PC [16:0/20:4], PC [20:4/20:4], LysoPC [18:0], and LysoPC [16:0]) metabolism, as well as other types of metabolism (arachidonic acid and palmitoylcarnitine). Notably, it was found that metabolite levels of TC group were partially reversed to normal. In conclusion, TC could ameliorate MCAO in rats by affecting energy metabolism (glycolysis and the TCA cycle), amino acid metabolism, glycerophospholipid metabolism, and other types of metabolism.
Collapse
Affiliation(s)
- Wenxing Liu
- 1 Department of Pharmacy, Xijing Hospital, the Fourth Military Medical University, Xi'an, China
| | - Fei Mu
- 1 Department of Pharmacy, Xijing Hospital, the Fourth Military Medical University, Xi'an, China
| | - Tianlong Liu
- 1 Department of Pharmacy, Xijing Hospital, the Fourth Military Medical University, Xi'an, China
| | - Hang Xu
- 1 Department of Pharmacy, Xijing Hospital, the Fourth Military Medical University, Xi'an, China
| | - Jianzong Chen
- 2 Research Center of Traditional Chinese Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, China
| | - Na Jia
- 1 Department of Pharmacy, Xijing Hospital, the Fourth Military Medical University, Xi'an, China
| | - Yikai Zhang
- 1 Department of Pharmacy, Xijing Hospital, the Fourth Military Medical University, Xi'an, China.,3 Department of Biochemistry, Shaanxi Institute of Medical Device Quality Supervision and Inspection, Xi'an, China
| | - Fang Dou
- 1 Department of Pharmacy, Xijing Hospital, the Fourth Military Medical University, Xi'an, China
| | - Lei Shi
- 4 Department of Pharmacy, Guangzhou General Hospital of Guangzhou Military Command, Guangzhou, China
| | - Yuwen Li
- 1 Department of Pharmacy, Xijing Hospital, the Fourth Military Medical University, Xi'an, China
| | - AiDong Wen
- 1 Department of Pharmacy, Xijing Hospital, the Fourth Military Medical University, Xi'an, China
| | - Yi Ding
- 1 Department of Pharmacy, Xijing Hospital, the Fourth Military Medical University, Xi'an, China.,4 Department of Pharmacy, Guangzhou General Hospital of Guangzhou Military Command, Guangzhou, China
| |
Collapse
|
10
|
Dou F, Miao H, Wang JW, Chen L, Wang M, Chen H, Wen AD, Zhao YY. An Integrated Lipidomics and Phenotype Study Reveals Protective Effect and Biochemical Mechanism of Traditionally Used Alisma orientale Juzepzuk in Chronic Kidney Disease. Front Pharmacol 2018; 9:53. [PMID: 29472858 PMCID: PMC5809464 DOI: 10.3389/fphar.2018.00053] [Citation(s) in RCA: 35] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2017] [Accepted: 01/15/2018] [Indexed: 01/02/2023] Open
Abstract
Alisma orientale Juzepzuk (AO) is widely used for various diuretic and nephropathic treatments in traditional Chinese medicines (TCM). In a clinical setting, AO is used as both a lipid-lowering and tubular interstitial fibrosis agent. However, the mechanisms of AO for the treatment of renal interstitial fibrosis and abnormal lipid metabolism are not well-understood. In this study, pharmacological and UPLC-HDMS-based lipidomic approaches were employed to investigate the lipid-lowering and tubular interstitial fibrosis effect of AO on rats with adenine-induced chronic kidney disease (CKD). Rats with CKD showed increased serum levels of creatinine and urea, tubular damage, and tubular interstitial fibrosis. Moreover, multiple lipid species were identified in CKD rats. Among these lipids, polyunsaturated fatty acid, eicosapentaenoic acid, 8,9-epoxyeicosatrienoic acid, and docosahexaenoic acid levels were significantly decreased in CKD rats compared to control rats. In CKD rats, up-regulation of the NF-κB pathway may impair polyunsaturated fatty acid metabolism, causing renal fibrosis. In addition, CKD rats showed significantly decreased diglyceride levels and increased triglyceride levels compared to the control group. Pathway over-representation analysis demonstrated that 30 metabolic pathways were associated with lipid species. AO treatment suppressed up-regulation of inflammation, and partly restored the deregulation of polyunsaturated fatty acids and glycerolipids metabolism. Our results indicated that AO treatment attenuated renal fibrosis by down-regulating inflammation, and mitigating lipid metabolism in CKD rats. In conclusion, this study has identified the therapeutic lipid-lowering and anti-fibrosis effects of AO on CKD.
Collapse
Affiliation(s)
- Fang Dou
- Department of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xi'an, China
| | - Hua Miao
- Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Northwest University, Xi'an, China
| | - Jing-Wen Wang
- Department of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xi'an, China
| | - Lin Chen
- Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Northwest University, Xi'an, China
| | - Ming Wang
- Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Northwest University, Xi'an, China
| | - Hua Chen
- Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Northwest University, Xi'an, China
| | - Ai-Dong Wen
- Department of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xi'an, China
| | - Ying-Yong Zhao
- Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Northwest University, Xi'an, China
| |
Collapse
|
11
|
Xu H, Liu W, Liu T, Su N, Guo C, Feng X, Dou F, Ding Y, Shi L, Wen A. Synergistic neuroprotective effects of Danshensu and hydroxysafflor yellow A on cerebral ischemia-reperfusion injury in rats. Oncotarget 2017; 8:115434-115443. [PMID: 29383171 PMCID: PMC5777783 DOI: 10.18632/oncotarget.23272] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2017] [Accepted: 12/05/2017] [Indexed: 02/01/2023] Open
Abstract
Ischemic stroke is a common cerebrovascular disease with substantial morbidity and mortality worldwide. However, therapeutic options to minimize the cerebral ischemia-reperfusion (I/R) injury are limited. In China, combination of herb Danshen (Salvia miltiorrhiza Bge) and Honghua (Carthamus tinctorius L.) is effective for stroke treatment in patients but its underlying mechanism requires further investigation. Our study was conducted to evaluate and explore the synergistic effects of two herb ingredients Danshensu and hydroxysafflor yellow A (HSYA) on cerebral ischemia-reperfusion (I/R) injury in rats. Rats were randomly assigned to the following five groups: sham group, model group, Danshensu group, HSYA group, and Danshensu+HSYA group. Under our experimental conditions in vitro, oxygen-glucose deprivation (OGD) model was established to determine the synergistic neuroprotective effects of Danshensu and HSYA. With such methods as neurological deficits scoring, TTC, HE and TUNEL staining, and ELISA detection, the results demonstrated that administration of either Danshensu or HSYA improved neurological defects and alleviated pro-inflammatory and oxidative stress reactions. Notably, combination of Danshensu and HSYA exerted more effective results than that used alone. Furthermore, western blot analysis results showed that Danshensu and HSYA combination displayed synergistic regulation on TLR4/NF-κB and Nrf2/HO-1 pathways. Consistently, Danshensu +HSYA group exhibits better neuroprotection in primary neurons with OGD model compared with Danshensu or HSYA group. Taken together, we found for the first time that Danshensu plus HSYA could achieve remarkable synergistic neuroprotective effects on I/R injury, which is related to the anti-inflammatory and antioxidant pathways.
Collapse
Affiliation(s)
- Hang Xu
- Department of Pharmacy, Xijing Hospital, The Fourth Military Medical University, Xi'an 710032, China
| | - WenXing Liu
- Department of Pharmacy, Xijing Hospital, The Fourth Military Medical University, Xi'an 710032, China
| | - TianLong Liu
- Department of Pharmacy, Xijing Hospital, The Fourth Military Medical University, Xi'an 710032, China
| | - Ning Su
- Department of Radiation Oncology, Xijing Hospital, The Fourth Military Medical University, Xi'an 710032, China
| | - Chao Guo
- Department of Pharmacy, Xijing Hospital, The Fourth Military Medical University, Xi'an 710032, China
| | - XiaoNa Feng
- Department of Pharmacy, Xijing Hospital, The Fourth Military Medical University, Xi'an 710032, China
| | - Fang Dou
- Department of Pharmacy, Xijing Hospital, The Fourth Military Medical University, Xi'an 710032, China
| | - Yi Ding
- Department of Pharmacy, Xijing Hospital, The Fourth Military Medical University, Xi'an 710032, China.,Department of Pharmacy, Guangzhou General Hospital of Guangzhou Military Command, Guangzhou 510010, China
| | - Lei Shi
- Department of Pharmacy, Guangzhou General Hospital of Guangzhou Military Command, Guangzhou 510010, China
| | - AiDong Wen
- Department of Pharmacy, Xijing Hospital, The Fourth Military Medical University, Xi'an 710032, China
| |
Collapse
|
12
|
Shang P, Liu T, Liu W, Li Y, Dou F, Zhang Y, Sun L, Zhang T, Zhu Z, Mu F, Ding Y, Wen A. Telmisartan improves vascular remodeling through ameliorating prooxidant and profibrotic mechanisms in hypertension via the involvement of transforming growth factor-β1. Mol Med Rep 2017; 16:4537-4544. [PMID: 28791353 PMCID: PMC5646990 DOI: 10.3892/mmr.2017.7177] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2016] [Accepted: 06/13/2017] [Indexed: 01/14/2023] Open
Abstract
Vascular remodeling is a common complication and pathological basis of hypertension. Transforming growth factor‑β1 (TGF‑β1)/small mothers against decapentaplegic 3 (Smad3) is considered a potential therapeutic target for vascular remodeling in hypertension. The present study aimed to demonstrate the antifibrotic effects of telmisartan and examined the potential mechanisms associated with its prevention of vascular remodeling. Spontaneously hypertensive rats (SHRs) were treated with telmisartan (20 mg/kg), and vascular contractility, reactivity and oxidative stress were preliminarily evaluated. Vascular pathological alterations and collagen deposition were assessed using hematoxylin and eosin, and Masson staining, respectively. The profibrotic factors, TGF‑β1 and Smad3 were evaluated using immunofluorescence and immunohistochemistry. The protein levels of TGF‑β1/Smad3, phosphorylated (p‑)Smad3, collagen‑1 and α-smooth muscle actin in the aorta were assessed using western blot analysis. It was found that telmisartan attenuated chronic vasoconstriction and oxidative stress in the SHRs, and improved vascular reactivity. Telmisartan also restored vascular pathological alterations and decreased collagen deposition. In the vascular wall of the SHRs, telmisartan effectively decreased the protein levels of TGF‑β1/Smad3 and p‑Smad3. Taken together, these findings indicated that telmisartan, with its antioxidant effect, prevented vascular remodeling in hypertension through preventing the TGF‑β1/Smad3 signaling pathway.
Collapse
Affiliation(s)
- Peijin Shang
- Department of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China
| | - Tianlong Liu
- Department of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China
| | - Wenxing Liu
- Department of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China
| | - Yuwen Li
- Department of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China
| | - Fang Dou
- Department of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China
| | - Yikai Zhang
- Department of Pharmacy, Chinese PLA Shenyang General Hospital, Shenyang, Liaoning 110016, P.R. China
| | - Lijuan Sun
- Department of Ophthalmology, Eye Institute of Chinese PLA, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China
| | - Tiejun Zhang
- Department of Neurosurgery, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, P.R. China
| | - Zhihui Zhu
- Department of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China
| | - Fei Mu
- Department of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China
| | - Yi Ding
- Department of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China
| | - Aidong Wen
- Department of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China
| |
Collapse
|
13
|
Chen L, Chen DQ, Wang M, Liu D, Chen H, Dou F, Vaziri ND, Zhao YY. Role of RAS/Wnt/β-catenin axis activation in the pathogenesis of podocyte injury and tubulo-interstitial nephropathy. Chem Biol Interact 2017; 273:56-72. [DOI: 10.1016/j.cbi.2017.05.025] [Citation(s) in RCA: 75] [Impact Index Per Article: 10.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2017] [Revised: 05/21/2017] [Accepted: 05/31/2017] [Indexed: 01/11/2023]
|
14
|
Cossu A, Dou F, Young GM, Nitin N. Biomarkers of oxidative damage in bacteria for the assessment of sanitation efficacy in lettuce wash water. Appl Microbiol Biotechnol 2017; 101:5365-5375. [PMID: 28508923 DOI: 10.1007/s00253-017-8314-5] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/08/2017] [Revised: 04/24/2017] [Accepted: 04/28/2017] [Indexed: 11/28/2022]
Abstract
In the fresh produce industry, validation of sanitation efficacy is critical to prevent cross-contamination of produce. The current validation approaches are either based on time-consuming plate counting assays or indirect measurements of chemical properties of wash water. In the study, the focus was to identify biomarkers that can provide direct assessment of oxidative damage in bacteria upon exposure to sanitizers in the presence of fresh produce and correlation of these oxidative biomarkers with logarithmic inactivation of bacteria. Two endogenous bacterial biomarkers, protein carbonylation and thiol oxidation, were evaluated for assessing oxidative damage in Escherichia coli O157:H7 and Listeria innocua during sanitation of pre-cut lettuce leaves with NaOCl or H2O2. Results show that NaOCl treatment was more effective than H2O2 for oxidation of both the intracellular thiols and protein carbonylation in the selected strains. Statistical analysis of the measurements illustrates that oxidation of the intracellular thiol induced by NaOCl or H2O2 was correlated with logarithmic reduction of E. coli O157:H7 and L. innocua. In contrast, changes in the protein carbonylation content were not correlated with reduction in bacterial cell viability. In summary, these results provide a novel approach to validate sanitation efficacy for the fresh produce industry.
Collapse
Affiliation(s)
- Andrea Cossu
- Department of Food Science and Technology, University of California, Davis, Robert Mondavi Institute South, 392 Old Davis Road, Davis, CA, 95616, USA
| | - Fang Dou
- Department of Food Science and Technology, University of California, Davis, Robert Mondavi Institute South, 392 Old Davis Road, Davis, CA, 95616, USA
| | - Glenn M Young
- Department of Food Science and Technology, University of California, Davis, Robert Mondavi Institute South, 392 Old Davis Road, Davis, CA, 95616, USA
| | - Nitin Nitin
- Department of Food Science and Technology, University of California, Davis, Robert Mondavi Institute South, 392 Old Davis Road, Davis, CA, 95616, USA.
- Department of Biological and Agricultural Engineering, University of California, Davis, Davis, CA, 95616, USA.
| |
Collapse
|
15
|
Dou F, Xi M, Wang J, Tian X, Hong L, Tang H, Wen A. alpha-Glucosidase and alpha-amylase inhibitory activities of saponins from traditional Chinese medicines in the treatment of diabetes mellitus. Pharmazie 2013. [PMID: 23700798 DOI: 10.1691/ph.2013.2753] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
Extracts of eleven traditional Chinese medicines (TCM) with a reputation of usefulness in treating diabetes mellitus were examined for alpha-glucosidase and alpha-amylase inhibitory activities in vitro. The extract with the highest activity was selected for further characterization. The extract of the root bark of Aralia taibaiensis (EAT) outperformed other extracts in the assays with IC50 values of 0.48 +/- 0.01 mg/mL (BSG), 0.41 +/- 0.02mg/mL (SCG), 0.61 +/- .03mg/mL (BLA) and 0.77 +/- 0.03mg/mL (PPA), respectively. To identify which constituents were responsible for the activities, thirteen triterpenoid saponins were isolated from EAT and examined for their inhibitory effects against alpha-glucosidase and alpha-amylase. The results revealed that saponins 2, 3, 4 (IC50: 0.83 +/- 0.05 microM for BSG and IC50: 0.72 +/- 0.03 microM for SCG), 5, 6, 7, 9, 10, 11 and 12 (IC50: 1.07 +/- 0.04 micro.M for BSG and IC50: 0.93 +/- 0.05 micro.M for SCG) showed alpha-glucosidase inhibitory activities, while 2, 3, 4 (IC50: 0.93 +/- 0.04 micro.M for PPA), 5, 6, 7, 9, 10, 11 and 12 (IC50: 1.02 +/- 0.03 micro.M for PPA) possessed significant alpha-amylase inhibitory activities. In addition, the structure-activity relationship of the thirteen saponins was discussed based on their structure features and diabetes mellitus related activities. It is suggested that the glucuronic acid unit at C-3 of the aglycone is the imperative functional group of the antidiabetic activities, and two characteristic structural features are responsible for the remarkable alpha-glucosidase and alpha-amylase inhibitory activities.
Collapse
Affiliation(s)
- Fang Dou
- Department of Pharmacy, Xijing Hospital, Fourth Military Medical University, Yangling, PR China
| | | | | | | | | | | | | |
Collapse
|
16
|
Bi L, Tian X, Dou F, Hong L, Tang H, Wang S. New antioxidant and antiglycation active triterpenoid saponins from the root bark of Aralia taibaiensis. Fitoterapia 2011; 83:234-40. [PMID: 22088497 DOI: 10.1016/j.fitote.2011.11.002] [Citation(s) in RCA: 38] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2011] [Revised: 10/25/2011] [Accepted: 11/01/2011] [Indexed: 11/16/2022]
Abstract
Four new oleanane type triterpenoid saponins (1-4) and a known saponin (5) were isolated from the root bark of Aralia taibaiensis Z.Z. Wang et H.C. Zheng. The structures of the four new compounds were elucidated as 3-O-{β-D-glucopyranosyl-(1→2)-[β-D-glucopyranosyl-(1→3)]-β-D-glucurono-pyranosyl}-olean-11,13(18)-diene-28-oic acid 28-O-β-D-glucopyranosyl ester (1), 3-O-{β-D-gluco-pyranosyl-(1→3)-[α-l-arabinofuranosyl-(1→4)]-β-D-glucuronopyranosyl}-olean-11,13(18)-diene-28-oic acid 28-O-β-D-glucopyranosyl ester (2), 3-O-{β-d-glucopyranosyl-(1→2)-[α-l-arabinofuranosyl-(1→4)]-β-D-glucuronopyranosyl}-oleanolic acid 28-O-β-D-glucopyranosyl ester (3) and 3-O-{β-D-glucopyranosyl-(1→2)-[β-D-glucopyranosyl-(1→3)]-β-D-glucuronopyranosyl}-oleanolic acid 28-O-β-D-glucopyranosyl ester (4), on the basis of extensive spectral analysis and chemical evidence. Compounds 1-5 exhibited moderate effects on antioxidant and antiglycation activities, which correlated with treatment of diabetes mellitus.
Collapse
Affiliation(s)
- Linlin Bi
- Institute of Materia Medica, School of Pharmacy, Fourth Military Medical University, Xi'an 710032, PR China
| | | | | | | | | | | |
Collapse
|
17
|
Zhu YH, Zhao M, Ren L, Tian D, Dou F, Wang JX. [Studies on the chemical constituents from the flowers of Ophiopogon japonicus]. Zhong Yao Cai 2011; 34:720-723. [PMID: 21954559] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Abstract
OBJECTIVE To study the chemical constituents from the flowers of Ophiopogon japonicus. METHODS Column chromatography and spectral analysis were used to isolate and identify the constituents. RESULTS Eleven compounds were obtained and identified as beta-sitosterol (I), diosgenin (II), daucosterol (III), ophiopogonin C' (IV), dioscin (V), 7-dihy-droxy-6-methyl-3-(4'-hydroxybenzyl) chroman-4-one(VI), luteolin (VII), kaempferol-3-O-beta-D-glucopyranosides (VIII), kaempferol-3-O-(6"-tigloyl) -beta-D-glucopyranosides (IX), kaempferol-3-O-(6"-acetyl) -beta-D-glucopyranosides (X), glucose (XI). CONCLUSION Eleven compounds are obtained from the flowers of O. japonicus for the first time. Compond VI is isolated as a simple substance compound of O. japonicus for the first time. Componds VII, VIII, IX and X are isolated from this genus for the first time.
Collapse
Affiliation(s)
- Yu-Hong Zhu
- Department of Pharmacy, School of Medicine, Xi'an Jiaotong University, Xi'an 710061, China.
| | | | | | | | | | | |
Collapse
|
18
|
Cheng XP, Chen S, Tian D, Ren L, Dou F, Wang JX. [Studies on the chemical constituents of the root tube from Pteroxygonum giraldii]. Zhong Yao Cai 2010; 33:1727-1730. [PMID: 21434433] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
OBJECTIVE To study the chemical constituents of the root tube from Pteroxygonum giraldii. METHODS Column chromatography and spectral analysis were used to isolate and identify the constituents. RESULTS Ten compounds were isolated and identified as beta-sitosterol (I), beta-sitosterol glucoside (II), 4', 5,5', 7-tetrahydroxy-3'-methoxy-3'-O-alpha-L-arabinopyranosyl flavone (III), gallic acid (IV), myricetin (V), annulatin (VI), 5,5', 7-trihydroxy-2',3-dimethoxy-4'-O-beta-D-glucopyranosyl flavone (VII), 2', 5,5',7-tetrahydroxy -3-methoxy-4'-O-beta-D-glucopyranoside flavone (VIII), myricetin-3-O-alpha-L-rhamnopyranoside (IX) and myricetin-3,4'-dimethyl ether( X). CONCLUSION Compounds I, II, V, VIII and X are isolated from Pteroxygonum giraldii for the first time.
Collapse
Affiliation(s)
- Xin-Ping Cheng
- Ruixin Pharmaceutical Co Ltd, Xi'an Jiaotong University, Xi'an 710061, China.
| | | | | | | | | | | |
Collapse
|
19
|
Yuan LD, Dou F, Liang YP, Xie W, Wang F, Zhang SQ, Dai ZY. [Fusion expression of cecropin X including the cleavage of FXa in Escherichia coli]. Sheng Wu Gong Cheng Xue Bao 2000; 16:411-4. [PMID: 11059293] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/18/2023]
Abstract
PCR method was used to introduce the code sequence of Factor Xa cleavage site to the 5' end of cecropin CMIV mutant gene X, then the gene was cloned into the expression vector pGEX-KG, and was highly expressed in E. coli BL21 by IPTG induction. The fusion protein was purified by affinity-chromatography and was cleaved by Factor Xa. Cecropin X with antibacterial activity was obtained after purified by ion-exchange chromatography.
Collapse
Affiliation(s)
- L D Yuan
- Department of Biochemistry, Nanjing University
| | | | | | | | | | | | | |
Collapse
|
20
|
Abstract
A novel method for post-treatment of gene-engineered proteins is reported. A coden of Cys-His unit is introduced into the N-terminal of cecropin CMIV by using PCR. The gene is expressed in E. coli fused with GST. After purification, the fusion protein is cleaved by [Pd(en)(H2O)2]2+ at the His-Arg bond and the cecropin CMIV with antibacterial activity is obtained. The preliminary results held some promise of success for application of the palladium(II) complex as cleavage agent for the production of peptide drugs from gene-engineering fusion proteins.
Collapse
Affiliation(s)
- F Dou
- Department of Biochemistry Nanjing University, PR China
| | | | | | | | | | | | | |
Collapse
|
21
|
Dou F, Xie W, Dong X, Xu X. The terminal structure plays an important role in the biological activity of cecropin CMIV. Sci China C Life Sci 1999; 42:494-500. [PMID: 18726513 DOI: 10.1007/bf02881773] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/08/1999] [Indexed: 05/26/2023]
Abstract
Antibacterial peptides have received increasing attention as a new pharmaceutical substance. But the molecular mechanism of lysis is still poorly understood. CMIV gene and mutant CMIV gene in GST fusion system were expressed. After cleaving with different cleavage reagents, the peptide with an excess of N-terminus and with an un-amidated C-terminus stopped the activity while the peptide with an excess Asn at the C-terminus had the activity level the same as natural CMIV. The results showed that the terminal structure of cecropin CMIV played an important role in its biological activity.
Collapse
Affiliation(s)
- F Dou
- State Key Laboratory of Pharmaceutical Biotechnology, Department of Biochemistry, Nanjing University, 210093, Nanjing, China
| | | | | | | |
Collapse
|
22
|
Zhou A, Jiang X, Dou F, Zhu D, Xu X. Renaturation, purification, and characterization of human plasminogen activator inhibitor type 2 (PAI-2) accumulated at high level in Escherichia coli. J Biochem 1997; 121:930-4. [PMID: 9192735 DOI: 10.1093/oxfordjournals.jbchem.a021675] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023] Open
Abstract
Plasminogen activator inhibitor 2 (PAI-2) is an important regulator of plasminogen activation, which inhibits both tissue-type plasminogen activator (tPA) and urokinase-type plasminogen activator (uPA). In this study we have developed a high-level expression system by inserting a modified PAI-2 gene downstream of the T7 promoter. The expression level of recombinant PAI-2 amounted to 55-60% of total microbial protein. By efficient renaturation and one-step purification, the recombinant protein was purified to homogeneity. The specific activity and yield of recombinant PAI-2 reached 33,000 IU/mg and 10 mg per gram wet weight of Escherichia coli cells, respectively. The second-order rate constant for uPA was 2.6-2.8 x 10(6) M(-1) x s(-1).
Collapse
Affiliation(s)
- A Zhou
- Department of Biochemistry and National Laboratory of Pharmaceutical Biotechnology, Nanjing University, P.R. China
| | | | | | | | | |
Collapse
|
23
|
Wang L, Wu H, Dou F, Xie W, Xu X. High-level expression of cecropin CMIV in E. coli from a fusion construct containing the human tumor necrosis factor. Biochem Mol Biol Int 1997; 41:1051-6. [PMID: 9137837 DOI: 10.1080/15216549700202121] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
Cecropin CMIV gene was fused to the 3'-terminus of the mutated tumor necrosis factor (TNFb) gene and the fusion gene was directly under the control of an inducible T7 promoter in pET-11d. This fusion gene was overexpressed in Escherichia coli with an expression level of approximate 40%-50% of total cellular proteins, and was produced mainly in the form of inclusion body. Peptide with antibacterial activity was obtained by cleaving the fusion protein with CNBr.
Collapse
Affiliation(s)
- L Wang
- Department of Biochemistry, Nanjing University, P.R. China
| | | | | | | | | |
Collapse
|